[HTML][HTML] Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in …
JF Fu, CJ Wen, TH Yen, LY Shih - Neoplasia, 2022 - Elsevier
The molecular mechanism of myeloid sarcoma (MS) formation remains nuclear. Our clinical
and mouse model findings from a previous study revealed that cooperation of KMT2A (MLL) …
and mouse model findings from a previous study revealed that cooperation of KMT2A (MLL) …
Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in a mouse …
JF Fu, CJ Wen, TH Yen, LY Shih - Neoplasia (New York …, 2022 - pubmed.ncbi.nlm.nih.gov
The molecular mechanism of myeloid sarcoma (MS) formation remains nuclear. Our clinical
and mouse model findings from a previous study revealed that cooperation of KMT2A (MLL) …
and mouse model findings from a previous study revealed that cooperation of KMT2A (MLL) …
[HTML][HTML] Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in …
JF Fu, CJ Wen, TH Yen, LY Shih - Neoplasia (New York, NY), 2022 - ncbi.nlm.nih.gov
The molecular mechanism of myeloid sarcoma (MS) formation remains nuclear. Our clinical
and mouse model findings from a previous study revealed that cooperation of KMT2A (MLL) …
and mouse model findings from a previous study revealed that cooperation of KMT2A (MLL) …
Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in a mouse …
JF Fu, CJ Wen, TH Yen, LY Shih - Neoplasia (New York, NY), 2022 - europepmc.org
The molecular mechanism of myeloid sarcoma (MS) formation remains nuclear. Our clinical
and mouse model findings from a previous study revealed that cooperation of KMT2A (MLL) …
and mouse model findings from a previous study revealed that cooperation of KMT2A (MLL) …